Feasibility study of a prototype extended-wear insulin infusion set in adults with type 1 diabetes.
Jasmin R KastnerNisha VenkateshKatie BrownDouglas B MuchmoreElif Ilhan EkinciSpiros FourlanosJeffrey I JosephMiami ShafeeqLeon ShiPoul StrangePaul J StrasmaDavid Norman O'NealPublished in: Diabetes, obesity & metabolism (2022)
Our preliminary observations confirm the tolerability of the prototype CBX IIS for extended wear, albeit with a deterioration in glucose control after the third day.